@Article{Tokarek2021,
journal="Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej",
issn="1734-9338",
volume="17",
number="2",
year="2021",
title="Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension",
abstract="Sympathetic renal denervation (RDN) has been demonstrated as a potential treatment option for patients with resistant hypertension [1]. Despite discouraging results after the SYMPLICITY HTN-3 trial several techniques and catheters were introduced to the market and data confirming adequate and effective denervation are growing [1, 2]. In current guidelines invasive methods are not recommended as routine treatment of resistant hypertension [3, 4]. However, a highly selected group of patients not responding to aggressive medical treatment might benefit from this method [1–4].",
author="Tokarek, Tomasz
and Rajtar-Salwa, Renata
and Rzeszutko, Łukasz
and Bartuś, Stanisław",
pages="239--241",
doi="10.5114/aic.2021.107513",
url="http://dx.doi.org/10.5114/aic.2021.107513"
}